Insulin-like growth factor-II (IGF-II) secreted by Ld1 overexpressing esophageal cancer xenografts can promote the growth of distant esophageal tumors and promote the metastasis of circulating cancer cells [37]. This evidence concerns the gene IGF2 and esophageal cancer.